‌

US Patent 9073890 Therapeutic compounds and related methods of use

Patent 9073890 was granted and assigned to Otsuka Pharmaceutical on July, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Otsuka Pharmaceutical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

90738900

Patent Inventor Names

Haruka Takahashi0

Shin Miyamura0

Tae Fukushima0

Takeshi Kuroda0

Abhishek Dogra0

Akira Takahashi0

Amy Elder0

Geraldine Harriman0

...

Date of Patent

July 7, 2015

Patent Application Number

135200180

Date Filed

December 30, 2010

Patent Citations Received

‌

US Patent 11661426 Imidazole-containing inhibitors of ALK2 kinase

Patent Primary Examiner

‌

Jeffrey H Murray

Patent abstract

Compounds, pharmaceutical compositions containing the compounds, and methods of using the compounds to treat a disorder, e.g., schizophrenia and cognitive deficit, in a subject are described herein. The compounds disclosed herein include quinoline and quinazoline-containing compounds that modulate striatal-enriched tyrosine phosphatase (STEP) activity.